Jonathan Anderman

Insider Reports History

Location
Boston, MA
Signature
/s/ Neil Lerner, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Anderman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Compass Therapeutics, Inc. General Counsel Common Stock 171,000 $884,070 $5.17 02 Jan 2026 Direct
Compass Therapeutics, Inc. General Counsel Stock Option (Right to Buy) 720,000 02 Jan 2026 Direct

Insider Reports Filed by Jonathan Anderman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CMPX Compass Therapeutics, Inc. 02 Jan 2026 2 +$775,500 4 General Counsel 05 Jan 2026, 16:32
CMPX Compass Therapeutics, Inc. 07 Apr 2025 1 +$30,800 4 Gen Counsel & Corporate Sec 08 Apr 2025, 09:30
CMPX Compass Therapeutics, Inc. 11 Feb 2025 1 $0 4 Sr VP, Gen Counsel & Corp Sec 13 Feb 2025, 17:09
CMPX Compass Therapeutics, Inc. 13 Aug 2024 1 $0 4 Sr VP, Gen Counsel & Corp Sec 14 Aug 2024, 08:49
CMPX Compass Therapeutics, Inc. 01 Aug 2024 0 $0 3 Sr VP, Gen Counsel & Corp Sec 09 Aug 2024, 16:07